| Literature DB >> 32922361 |
Xianliang Meng1,2, Mengqian Zhang3,4, Baoquan Gao2,3, Jianjian Lv2,3, Jian Li2,3, Ping Liu2,3.
Abstract
Eyestalk ablation is the most common method to induce ovarian maturation in decapod crustacean aquaculture, but it jeopardizes broodstock survival and larvae production. It is important to understand the molecular basis underlying the maturation triggered by ablation and thereby develop an alternative measure for maturation manipulation. In this study, we investigate alterations of ovarian proteome and miRNA profile after ablation in a commercially important marine crab Portunus trituberculatus. Quantitative proteomic analysis using iTRAQ reveals that 163 proteins are differentially expressed following ablation, and modulation of methyl farnesoate metabolism and activation of calcium signaling may play important roles in the ovarian maturation induced by ablation. miRNA expression profiling identifies 31 miRNAs that show statistically significant changes. Integration of miRNA and proteome expression data with miRNA target prediction algorithms generates a potential regulatory network consisting of 26 miRNAs and 30 proteins linked by 71 possible functional associations. The miRNA-protein network analysis suggests that miRNAs are involved in promoting ovarian maturation by controlling expression of proteins related to methyl farnesoate synthesis, calcium signals, and energy metabolism. Experimental validation and temporal expression analysis indicate multiple miRNAs can act synergistically to regulate expression of Farnesoic acid O-methyltransferase and Calmodulin. Our findings provide new insights for elucidating the mechanisms underlying eyestalk ablation-induced ovarian maturation and could be useful for devising an alternative technique for manipulating reproduction in P. trituberculatus and other decapods.Entities:
Keywords: crab; eyestalk ablation; miRNA; ovarian development; proteome
Mesh:
Substances:
Year: 2020 PMID: 32922361 PMCID: PMC7456853 DOI: 10.3389/fendo.2020.00533
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
List of the annotated proteins that exhibited differentially expression after ESA.
| 1 | XP_003702718.1 | Peritrophin-1-like | 3.66 |
| 2 | XP_012151113.1 | Fibrillin-2-like isoform X2 | 3.08 |
| 3 | AAY56093.1 | Death-associated protein-like | 2.32 |
| 4 | ACZ02405.1 | Heat shock protein 70 | 2.28 |
| 5 | XP_003248548.1 | Clathrin light chain-like | 1.95 |
| 6 | XP_002431005.1 | Ubiquitin-fold modifier 1 precursor | 1.90 |
| 7 | XP_002404909.1 | Prefoldin | 1.84 |
| 8 | AFE88627.1 | Thioredoxin 2 | 1.79 |
| 9 | KDR08860.1 | Tumor protein D54 | 1.79 |
| 10 | XP_004922887.1 | BolA-like protein | 1.76 |
| 11 | XP_012176731.1 | Fibril-forming collagen alpha chain like | 1.76 |
| 12 | XP_974307.1 | Similar to par-6 gamma | 1.74 |
| 13 | ADZ96217.1 | JHE-like carboxylesterase 1 | 1.70 |
| 14 | EFN74540.1 | Sorting nexin-12 | 1.70 |
| 15 | AFS60116.1 | Selenoprotein M | 1.69 |
| 16 | NP_001037686.1 | Aspartylglucosaminidase | 1.67 |
| 17 | BAJ22990.1 | Cytochrome c | 1.67 |
| 18 | ACL26692.1 | Farnesoic acid O-methyltransferase | 1.67 |
| 19 | XP_001865898.1 | Antioxidant enzyme | 1.66 |
| 20 | AAY57406.1 | Program cell death 5-like | 1.66 |
| 21 | ACU82846.1 | Acyl-CoA-binding protein | 1.64 |
| 22 | ACO11851.1 | RNA-binding protein 1 | 1.64 |
| 23 | AAO73307.1 | Ovary development-related protein | 1.63 |
| 24 | ACO11926.1 | Charged multivesicular body protein 5 | 1.61 |
| 25 | ACJ53746.1 | Peroxiredoxin 6 | 1.61 |
| 26 | XP_001942794.1 | 39S ribosomal protein L12, mitochondrial-like isoform 1 | 1.60 |
| 27 | ACL13568.1 | AMP-activated protein kinase alpha subunit | 1.60 |
| 28 | ACY66390.1 | FK506-binding protein 1A | 1.60 |
| 29 | ABI98678.1 | Ubiquitin-conjugating enzyme | 1.59 |
| 30 | XP_972770.2 | Insulin receptor | 1.58 |
| 31 | ADE60733.1 | Myosin essential light chain | 1.57 |
| 32 | NP_001103783.1 | Tropomyosin-2 isoform 3 | 1.57 |
| 33 | ABF55966.2 | Cleavage stimulation factor 64-kDa subunit | 1.56 |
| 34 | EFN66390.1 | PERQ amino acid-rich with GYF domain-containing protein 2 | 1.56 |
| 35 | XP_796085.2 | Transcription and mRNA export factor ENY2 | 1.56 |
| 36 | XP_011300302.1 | Prefoldin subunit 1 | 1.55 |
| 37 | KDR23647.1 | Protein phosphatase inhibitor 2 | 1.55 |
| 38 | ACR56783.1 | Small ubiquitin-like modifier-1 | 1.55 |
| 39 | ACY66642.1 | Thymosin beta | 1.55 |
| 40 | EGI57685.1 | Non-specific lipid-transfer protein | 1.54 |
| 41 | KDR12501.1 | Spondin-1 | 1.54 |
| 42 | EFN86015.1 | GS1-like protein | 1.53 |
| 43 | XP_003723328.1 | ES1 protein homolog, mitochondrial-like | 1.52 |
| 44 | XP_011501070.1 | Far upstream element-binding protein 1 isoform X3 | 1.52 |
| 45 | XP_003445744.1 | Methylmalonyl-CoA epimerase | 1.52 |
| 46 | EGW07359.1 | Peptidyl-prolyl cis-trans isomerase, mitochondrial | 1.52 |
| 47 | XP_008470922.1 | Verprolin-like | 1.52 |
| 48 | XP_003451145.1 | Aminopeptidase W07G4.4-like | 1.51 |
| 49 | XP_012259502.1 | DnaJ homolog subfamily B member 11 | 1.51 |
| 50 | XP_001847373.1 | Ubiquinol-cytochrome c reductase complex 14 kDa protein | 1.51 |
| 51 | ADW24146.1 | Vesicle-associated membrane protein-associated protein | 1.5 |
| 52 | AAX94762.1 | Vitellogenin | 1.5 |
| 53 | XP_003707900.1 | 28S ribosomal protein S36, mitochondrial-like | 1.49 |
| 54 | XP_002427853.1 | Protein-L-isoaspartate O-methyltransferase | 1.48 |
| 55 | BAM18170.1 | Prefoldin subunit | 1.47 |
| 56 | AGF39576.1 | Double WAP domain-containing protein | 1.46 |
| 57 | XP_002413321.1 | LIM domain-binding protein | 1.46 |
| 58 | XP_001660469.1 | Low-density lipoprotein receptor | 1.46 |
| 59 | EGI66356.1 | Prefoldin subunit 2 | 1.46 |
| 60 | ELW71144.1 | Calmodulin | 1.45 |
| 61 | KDR23803.1 | Outer dense fiber protein 3 | 1.45 |
| 62 | XP_001947263.2 | Upstream activation factor subunit spp27-like | 1.45 |
| 63 | XP_008473520.1 | Pumilio homolog 1-like | 1.44 |
| 64 | NP_001090127.1 | Tubulin folding cofactor B | 1.44 |
| 65 | ACO36738.1 | Ubiquitin carboxyl-terminal esterase L3 | 1.43 |
| 66 | KMQ90936.1 | Barrier-to-autointegration factor | 1.42 |
| 67 | NP_001156264.1 | Calcium-regulated heat stable protein 1 | 1.42 |
| 68 | XP_002423140.1 | Charged multivesicular body protein 4C | 1.42 |
| 69 | XP_003690694.1 | Synaptosomal-associated protein 29-like | 1.42 |
| 70 | ACI13851.1 | Extracellular copper-zinc superoxide dismutase | 1.41 |
| 71 | XP_002425615.1 | Methionyl-tRNA synthetase | 1.41 |
| 72 | XP_008199673.1 | Nuclear protein MDM1 isoform X4 | 1.41 |
| 73 | XP_003486756.1 | Stress-induced-phosphoprotein 1-like isoform 1 | 1.41 |
| 74 | ETN61219.1 | Aldehyde oxidase | 1.40 |
| 75 | ADO00931.1 | Calnexin | 1.40 |
| 76 | XP_002413938.1 | Low-density lipoprotein receptor | 1.40 |
| 77 | KDR20387.1 | Phosphoglycerate mutase 2 | 1.40 |
| 78 | ACY66501.1 | 60S acidic ribosomal protein P2 | 1.39 |
| 79 | XP_004065994.1 | Cytosol aminopeptidase-like | 1.39 |
| 80 | XP_011416416.1 | Histidine triad nucleotide-binding protein 2 | 1.39 |
| 81 | EKC27215.1 | Ras GTPase-activating protein-binding protein 2 | 1.39 |
| 82 | EKC33829.1 | Methenyltetrahydrofolate synthetase domain-containing protein | 1.38 |
| 83 | XP_011157802.1 | Short-chain specific acyl-CoA dehydrogenase | 1.38 |
| 84 | XP_012150508.1 | Multiple coagulation factor deficiency protein 2 homolog | 1.37 |
| 85 | XP_002409815.1 | PDZ domain-containing protein | 1.37 |
| 86 | XP_001943654.1 | Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase | 1.36 |
| 87 | NP_001164152.1 | Held out wings | 1.36 |
| 88 | ACR54112.1 | Ribosomal protein P1 | 1.36 |
| 89 | KDR12892.1 | Syntaxin-12 | 1.36 |
| 90 | XP_003400244.1 | Cyclin-dependent kinase 6-like | 1.35 |
| 91 | XP_005175277.1 | ATP synthase subunit d | 1.34 |
| 92 | ACH88358.1 | Cell division cycle 2 | 1.34 |
| 93 | ADN52396.1 | Triosephosphate isomerase | 1.34 |
| 94 | EFA07536.1 | RAE1 RNA export 1 homolog | 1.33 |
| 95 | ACO14747.1 | Calponin-3 | 1.32 |
| 96 | NP_001020355.1 | DnaJ homolog subfamily B member 9 precursor | 1.32 |
| 97 | ACZ06791.1 | Eukaryotic translation initiation factor 5A | 1.32 |
| 98 | AET36895.1 | Peroxiredoxin 2 | 1.32 |
| 99 | AAC78141.1 | Phosphopyruvate hydratase | 1.32 |
| 100 | AFC17961.1 | O-methyltransferase | 1.31 |
| 101 | XP_002415663.1 | Alternative splicing factor ASF/SF2 | 1.30 |
| 102 | EKC42097.1 | Cathepsin F | 1.28 |
| 103 | ACI46952.1 | Cyclin B | 1.28 |
| 104 | KDR07772.1 | Plastin-2 | 1.28 |
| 105 | XP_012267954.1 | Golgi resident protein GCP60 | 1.27 |
| 106 | XP_972648.1 | Similar to adaptin ear-binding coat-associated protein 2 | 1.25 |
| 107 | ACY66506.1 | Ubiquitin associated protein 2-like protein | 1.25 |
| 108 | KFM60612.1 | DnaJ-like protein subfamily A member 2 | 1.24 |
| 109 | XP_003705474.1 | Aconitate hydratase | 1.23 |
| 110 | ADQ55791.1 | Antimicrobial peptide hyastatin | 1.23 |
| 111 | CAA72032.2 | Masquerade-like protein | 1.22 |
| 112 | XP_973346.1 | Phosphoacetylglucosamine mutase | 0.83 |
| 113 | AAC64660.1 | Pacifastin heavy chain precursor | 0.82 |
| 114 | AEF32710.1 | Translationally controlled tumor protein | 0.81 |
| 115 | ACY66537.1 | 60S ribosomal protein L27 | 0.80 |
| 116 | AAZ22828.1 | Lymphoid organ expressed yellow head virus receptor protein | 0.80 |
| 117 | KFM60603.1 | 60S ribosomal protein L7a | 0.79 |
| 118 | ABQ10738.1 | Cathepsin D | 0.79 |
| 119 | XP_011136175.1 | Proteasome subunit alpha type-5 | 0.79 |
| 120 | XP_972566.1 | Succinate semialdehyde dehydrogenase, mitochondrial | 0.79 |
| 121 | AET34923.1 | Peroxiredoxin 1 | 0.78 |
| 122 | XP_002401133.1 | Ribosomal protein S26 | 0.78 |
| 123 | NP_001037263.1 | Ribosomal protein S8 | 0.77 |
| 124 | XP_003705948.1 | 1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase-like | 0.75 |
| 125 | XP_002423307.1 | cAMP-dependent protein kinase catalytic subunit | 0.73 |
| 126 | ACN87221.1 | Phenoloxidase activating factor | 0.72 |
| 127 | XP_007442568.1 | Glutathione peroxidase 7-like | 0.71 |
| 128 | KFM75426.1 | Protein canopy-like protein | 0.71 |
| 129 | ABX71209.1 | Glycosyl-phosphatidylinositol-linked carbonic anhydrase | 0.69 |
| 130 | AAW57889.1 | Hemocyanin subunit 1 | 0.69 |
| 131 | AAW57890.1 | Hemocyanin subunit 2 | 0.69 |
| 132 | AAW57891.1 | Hemocyanin subunit 3 | 0.65 |
| 133 | AAA96966.2 | Hemocyanin subunit 6 | 0.59 |
| 134 | AAF64305.1 | Hemocyanin subunit | 0.56 |
| 135 | EGI63299.1 | Histone-lysine N-methyltransferase trr | 0.24 |
Figure 1Gene ontology (GO) classification diagram of differentially expressed proteins in the ovary of ESA and ESI crabs. Red and blue represent upregulated and downregulated proteins after ESA, respectively.
Figure 2Volcano plot of differentially expressed miRNAs in the ovary of ESA and ESI crabs. Gray, red, and blue dots represent non-significant, upregulated, and downregulated miRNAs after ESA, respectively.
Figure 3The miRNA-protein regulatory network constructed on the basis of in silico miRNA target prediction and inverse correlation of protein and miRNAs expression after ESA. Upregulated miRNAs and proteins are represented in red, and downregulated miRNAs and proteins are represented in blue. The abbreviations in the figure: RPLP2, 60S acidic ribosomal protein P2; NECAP, Adaptin ear-binding coat-associated protein 2; AMPK, AMP-activated protein kinase alpha subunit; AGA, Aspartylglucosaminidase; CRHSP1, Calcium-regulated heat stable protein 1; CAM, Calmodulin; CAN, Calnexin; CATD, Cathepsin D; CATF, Cathepsin F; CATF, Cathepsin F; CYCB, Cyclin B; CYTC, Cytochrome c; DNAJ, DnaJ homolog subfamily B member 9 precursor; EIF5A, Eukaryotic translation initiation factor 5A; FAMET, Farnesoic acid O-methyltransferase; IR, Insulin receptor; MAS, Masquerade-like protein; NSLTP, Non-specific lipid-transfer protein; PRDX1, Peroxiredoxin 1; PRDX2, Peroxiredoxin 2; PRDX6, Peroxiredoxin 6; PPH, Phosphopyruvate hydratase; PFD, Prefoldin; PFD2, Prefoldin subunit 2; PCDC5, Program cell death 5-like; PIMT, Protein-L-isoaspartate O-methyltransferase; RAE1, RAE1 RNA export 1 homolog; RPS26, Ribosomal protein S26; SNX12, Sorting nexin-12; Tβ, Thymosin beta; TPI, Triosephosphate isomerase.
A list of significantly altered miRNAs and target proteins showing inverse correlation of expression after ESA.
| let-7 | 0.39 | Non-specific lipid-transfer protein | 1.54 |
| Prefoldin subunit 2 | 1.46 | ||
| miR-2b | 0.41 | Calmodulin | 1.45 |
| Cathepsin F | 1.28 | ||
| Eukaryotic translation initiation factor 5A | 1.32 | ||
| miR-98 | 0.39 | Non-specific lipid-transfer protein | 1.54 |
| Prefoldin subunit 2 | 1.46 | ||
| miR-219-1-3p | 0.43 | Calcium-regulated heat stable protein 1 | 1.42 |
| Cyclin B | 1.28 | ||
| Non-specific lipid-transfer protein | 1.54 | ||
| Sorting nexin-12 | 1.70 | ||
| Triosephosphate isomerase | 1.34 | ||
| miR-219b-3p | 0.40 | Cyclin B | 1.28 |
| Masquerade-like protein | 1.22 | ||
| Sorting nexin-12 | 1.70 | ||
| miR-263a | 0.47 | Farnesoic acid O-methyltransferase | 1.67 |
| miR-317 | 0.21 | Calmodulin | 1.45 |
| miR-466b-3p | 0.41 | Calmodulin | 1.45 |
| Cathepsin F | 1.28 | ||
| Insulin receptor | 1.58 | ||
| Masquerade-like protein | 1.22 | ||
| Sorting nexin-12 | 1.70 | ||
| Triosephosphate isomerase | 1.34 | ||
| miR-3907 | 0.49 | AMP-activated protein kinase alpha subunit | 1.60 |
| miR-4171 | 0.39 | Farnesoic acid O-methyltransferase | 1.67 |
| novel-5 | 2.69 | Cathepsin D | 0.79 |
| novel-61 | 0.29 | Aspartylglucosaminidase | 1.67 |
| Calmodulin | 1.45 | ||
| novel-65 | 2.80 | Peroxiredoxin 1 | 0.78 |
| novel-68 | 0.34 | Cyclin B | 1.28 |
| novel-72 | 0.37 | 60S acidic ribosomal protein P2 | 1.39 |
| Calcium-regulated heat stable protein 1 | 1.42 | ||
| Cathepsin F | 1.28 | ||
| Prefoldin | 1.84 | ||
| novel-75 | 0.47 | Cathepsin F | 1.28 |
| DnaJ homolog subfamily B member 9 precursor | 1.32 | ||
| Insulin receptor | 1.58 | ||
| RAE1 RNA export 1 homolog | 1.33 | ||
| novel-77 | 0.38 | AMP-activated protein kinase alpha subunit | 1.60 |
| Cyclin B | 1.28 | ||
| Eukaryotic translation initiation factor 5A | 1.32 | ||
| Phosphopyruvate hydratase | 1.32 | ||
| Prefoldin | 1.84 | ||
| novel-85 | 0.21 | Calnexin | 1.40 |
| Cyclin B | 1.28 | ||
| Program cell death 5-like | 1.66 | ||
| novel-96 | 0.44 | 60S acidic ribosomal protein P2 | 1.39 |
| AMP-activated protein kinase alpha subunit | 1.60 | ||
| Calnexin | 1.40 | ||
| Cytochrome c | 1.67 | ||
| Peroxiredoxin 6 | 1.61 | ||
| Phosphopyruvate hydratase | 1.32 | ||
| Calmodulin | 1.45 | ||
| novel-100 | 0.44 | Program cell death 5-like | 1.66 |
| novel-112 | 0.32 | Aspartylglucosaminidase | 1.67 |
| Similar to adaptin ear-binding coat-associated protein 2 | 1.25 | ||
| novel-134 | 3.45 | Ribosomal protein S26 | 0.78 |
| novel-136 | 0.46 | AMP-activated protein kinase alpha subunit | 1.60 |
| Eukaryotic translation initiation factor 5A | 1.32 | ||
| Non-specific lipid-transfer protein | 1.54 | ||
| Triosephosphate isomerase | 1.34 | ||
| novel-142 | 0.44 | Calcium-regulated heat stable protein 1 | 1.42 |
| Calnexin | 1.40 | ||
| Triosephosphate isomerase | 1.34 | ||
| novel-154 | 0.08 | Aspartylglucosaminidase | 1.67 |
| novel-167 | 0.47 | AMP-activated protein kinase alpha subunit | 1.60 |
| Peroxiredoxin 2 | 1.32 | ||
| Phosphopyruvate hydratase | 1.32 | ||
| Protein-L-isoaspartate O-methyltransferase | 1.48 | ||
| Thymosin beta | 1.55 |
Figure 4Predicted binding sites of the miRNAs in the 3′ UTRs of their target (A) and validation of interactions between the selected pairs of miRNAs and their targets, including miR-263a/FAMeT (B), miR-4171/FAMeT (C), miR-2b/CaM (D), miR-317/CaM (E) and miR-466b-3p/CaM (F), via dual luciferase reporter assay. Above the histograms, nucleotide sequences of miRNAs and targets wild-type and mutant 3′ UTR regions are shown. The histograms present relative luciferase activity in HEK293T cells cotransfected with miRNA mimics or miRNA negative control, and pmirGLO vector containing wild-type or mutant 3′ UTR regions of miRNA targets. The relative luciferase activity was calculated by normalizing firefly luciferase activity to Renilla luciferase activity. Different letters on the bars indicate significant differences based on one-way ANOVA followed by Tukey's HSD multiple comparison test (p < 0.05).
Figure 5The relative expression of FAMeT (A) and CaM (D) and their corresponding miRNAs, including miR-263a (B), miR-4171 (C), miR-2b (E), miR-317 (F), and miR-466f-3p (G) at 0, 24, 48, 72, 96, and 168 h after ESA. The asterisk indicates that the expression significantly differs from that at 0 h (p < 0.05).